| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.13 Billion | USD 4.97 Billion | 8.84% | 2024 |
FrequentlyAsked Questions
The global supraglottic airway management devices market is expected to grow due to rising prevalence of respiratory emergencies, increasing surgical procedures, demand for minimally invasive techniques, and advancements in anesthesia administration.
According to a study, the global supraglottic airway management devices market size was worth around USD 2.13 Billion in 2024 and is expected to reach USD 4.97 Billion by 2034.
The global supraglottic airway management devices market is expected to grow at a CAGR of 8.84% during the forecast period.
North America is expected to dominate the supraglottic airway management devices market over the forecast period.
Leading players in the global supraglottic airway management devices market include Intersurgical Ltd. (U.K.), Olympus Corporation (Japan), BD (U.S.), Teleflex Incorporated (U.S.), Armstrong Medical Inc. (U.K.), Medline Industries, Inc. (U.S.), Rudolf Riester GmbH (Germany), General Electric (U.S.), Mercury Medical (U.S.), Smiths Group plc (U.K.), Verathon Inc. (U.S.), VBM Medizintechnik GmbH (Germany), SunMed (U.S.), Medtronic (Ireland), Flexicare (Group) Limited (U.K.), VYAIRE (U.S.), Ambu A/S (Denmark), among others.
The report explores crucial aspects of the supraglottic airway management devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients